Healthy Extracts (HYEX) Cash & Current Investments (2015 - 2026)
Healthy Extracts (HYEX) posted quarterly Cash & Current Investments of $146935.0 for Q4 2025, up 13.98% year-over-year from $128910.0 in Q4 2024, and down 22.44% quarter-over-quarter from $189452.0 in Q3 2025.
Healthy Extracts (HYEX) Cash & Current Investments (2015 - 2026) Analysis & Trends
Healthy Extracts' Cash & Current Investments history runs 11 years deep, the most recent figure standing at $146935.0 for Q4 2025.
- In Q4 2025, Cash & Current Investments rose 13.98% year-over-year to $146935.0; the TTM figure through Dec 2025 stood at $146935.0 (up 13.98% YoY), while the FY2025 annual figure was $146935.0, up 13.98% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $146935.0, down from $189452.0 in the prior quarter.
- The five-year high for Cash & Current Investments was $286939.0 in Q2 2021, with the low at $19441.0 in Q4 2023.
- The 5-year median for Cash & Current Investments is $123854.0 (2024), against an average of $137020.2.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments slumped 70.44% in 2022, then soared 563.08% in 2024.
- Healthy Extracts' Cash & Current Investments stood at $222098.0 in 2021, then plunged by 70.44% to $65651.0 in 2022, then plunged by 70.39% to $19441.0 in 2023, then jumped by 563.08% to $128910.0 in 2024, then rose by 13.98% to $146935.0 in 2025.
- Business Quant data shows HYEX's Cash & Current Investments at $146935.0 in Q4 2025, $189452.0 in Q3 2025, and $200494.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | Healthy Extracts | 19.12 Mn | 18.93 Mn | 1.45 Mn | 189,958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 189,958.00 |
| Dec 31, 2025 | 146,935.00 |
| Sep 30, 2025 | 189,452.00 |
| Jun 30, 2025 | 200,494.00 |
| Mar 31, 2025 | 118,798.00 |
| Dec 31, 2024 | 128,910.00 |
| Sep 30, 2024 | 100,402.00 |
| Jun 30, 2024 | 148,231.00 |
| Mar 31, 2024 | 87,312.00 |
| Dec 31, 2023 | 19,441.00 |
| Sep 30, 2023 | 46,391.00 |
| Jun 30, 2023 | 92,501.00 |
| Mar 31, 2023 | 213,204.00 |
| Dec 31, 2022 | 65,651.00 |
| Sep 30, 2022 | 73,884.00 |
| Jun 30, 2022 | 159,405.00 |
| Mar 31, 2022 | 92,286.00 |
| Dec 31, 2021 | 222,098.00 |
| Sep 30, 2021 | 115,138.00 |
| Jun 30, 2021 | 286,939.00 |